Our products
GHRH analogue
CJC-1295 No DAC
A name commonly used for modified GRF (1–29), a growth hormone-releasing hormone analogue without a drug affinity complex.
How it works
GHRH analogues activate growth hormone-releasing hormone receptors on pituitary cells, stimulating growth hormone release. Without the drug affinity complex (DAC), the peptide does not have the same prolonged albumin-binding action as CJC-1295 with DAC.
Research context
Naming is not consistent across research catalogues. Published human studies of CJC-1295 with DAC should not be treated as evidence for the no-DAC material. It is not an approved medicine.